JP
BIO icon

JNE Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

JNE Partners’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26M Sell
88,511
-3,589
-4% -$1.02M 10.69% 4
2026
Q1 		$25.7M Hold
92,100
– – 10.5% 5
2025
Q4 		$27.9M Hold
92,100
– – 11.59% 5
2025
Q3 		$25.8M Hold
92,100
– – 10.99% 4
2025
Q2 		$22.2M Buy
+92,100
New +$21.8M 8.94% 4

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JNE Partners's BIO Position: Q2 2026 in Review

JNE Partners reduced its Bio-Rad Laboratories Class A (BIO) stake by 3.9% in Q2 2026, selling an estimated $1.02M and leaving 88,511 shares worth $26M. The position accounts for 10.69% of the portfolio, ranked #4.

JNE Partners first reported a position in BIO in Q2 2025 and has held it in 5 quarters since. The position peaked at $27.9M in Q4 2025. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • JNE Partners held 88,511 shares of Bio-Rad Laboratories Class A worth $26M as of Q2 2026.
  • JNE Partners sold 3,589 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $1.02M.
  • Bio-Rad Laboratories Class A made up 10.69% of JNE Partners's portfolio in Q2 2026, its #4 holding.
  • JNE Partners first reported a position in Bio-Rad Laboratories Class A in Q2 2025 and has held it in 5 quarters since.
  • JNE Partners's Bio-Rad Laboratories Class A position peaked at $27.9M in Q4 2025.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on JNE Partners's 13F filing for Q2 2026, filed 14 Aug 2026.